Xenetic Biosciences, Inc. (XBIO) › RevenueXenetic Biosciences, Inc. (XBIO) — RevenueAnnual figures by fiscal year, from SEC filings.2012: $293.6K2013: $1.00M2014: $02015: $02016: $3.00M2017: $7.58M2018: $02019: $17.1K2020: $436.9K2021: $1.16M2022: $1.71M2023: $2.54M2024: $2.50M2025: $2.98M$2.98M2012Revenue (USD)2025Fiscal YearRevenueChange YoY2025$2.98M+19.0%2024$2.50M-1.6%2023$2.54M+48.8%2022$1.71M+47.1%2021$1.16M+165.6%2020$436.9K+2460.3%2019$17.1K—2018$0-100.0%2017$7.58M+152.8%2016$3.00M—2015$0—2014$0-100.0%2013$1.00M+240.6%2012$293.6K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share